I-SENS, Inc. announces an Equity Buyback for KRW 3,000 million worth of its shares.
August 20, 2018 at 08:11 am IST
Share
i-SENS, Inc. (KOSDAQ:A099190) announces a share repurchase program. Under the program, the company will repurchase up to KRW 3,000 million worth of its shares, pursuant to a contract with NH Investment & Securities Co., Ltd. The purpose of the program is to increase shareholder value and stabilize share price. The program will expire on February 19, 2019. As of August 19, 2018, the company had no shares in treasury within scope available for dividend and had 940 shares in treasury under other capacities.
i-SENS, Inc. is a Korea-based company mainly engaged in the manufacture and sale of biosensors. The Companyâs products consist of blood glucose monitoring systems, including blood glucose monitors, blood glucose meters, glucose monitors, blood glucose meter kits and blood sugar meters under the brand names of CareSens, MedTrust, BGStar, Barozen and others; electrolyte analyzers and cartridges; immunosensors, as well as other related accessories, such as connectors, lancets, blood glucose data management software and lancing devices, among others. The Company distributes its products within domestic market and to overseas markets including Japan, Europe, the United States and others.
I-SENS, INC. 
